A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
- Conditions
- RegurgitationGastroesophageal RefluxHeartburn
- Interventions
- Other: Breath Testing
- Registration Number
- NCT05976165
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Breath Test Evaluation for SIBO Breath Testing Subjects with symptoms of gastroesophageal reflux disease (GERD) treated with a short course of proton pump inhibitors (PPI) clinically will undergo breath testing evaluating for small intestinal bacterial overgrowth (SIBO).
- Primary Outcome Measures
Name Time Method Incidence of SIBO after treatment with PPI After PPI therapy, approximately 8 weeks Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) after clinical treatment of proton pump inhibitors (PPI ).
- Secondary Outcome Measures
Name Time Method Symptoms of SIBO after treatment with PPI After PPI therapy, approximately 8 weeks Measured using the self-reported Mayo Bloating Questionnaire to assess symptoms of bloating and abdominal distension. Comprised of 45 questions addressing symptoms of bloating/distention. Other questionnaires include a diarrhea survey and the GERDQ.
Symptoms of SIBO before treatment with a PPI Baseline Measured using the self-reported Mayo Bloating Questionnaire to assess symptoms of bloating and abdominal distension. Comprised of 45 questions addressing symptoms of bloating/distention. Other questionnaires include a diarrhea survey and the GERDQ.
Incidence of SIBO before treatment with a PPI Baseline Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) before clinical treatment of proton pump inhibitors (PPI ).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Mayo Clinic Florida
🇺🇸Jacksonville, Florida, United States